Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ilrwpwwpwrrk-amide
2. Mbi-226
1. Mbi 226
2. 269062-93-3
3. Omiganan Hcl
4. Unii-lx2p9rd54v
5. Mbi-226
6. Omiganan Pentahydrochloride [usan]
7. Lx2p9rd54v
8. Chembl1793889
9. 626233-83-8
10. L-isoleucyl-l-leucyl-l-arginyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-arginyl-l-arginyl-l-lysinamide Pentahydrochloride
11. L-lysinamide, L-isoleucyl-l-leucyl-l-arginyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-arginyl-l-arginyl-, Hydrochloride (1:5)
12. L-lysinamide, L-isoleucyl-l-leucyl-l-arginyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-tryptophyl-l-prolyl-l-tryptophyl-l-arginyl-l-arginyl-, Pentahydrochloride
| Molecular Weight | 1961.4 g/mol |
|---|---|
| Molecular Formula | C90H132Cl5N27O12 |
| Hydrogen Bond Donor Count | 30 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 52 |
| Exact Mass | 1959.896191 g/mol |
| Monoisotopic Mass | 1957.899141 g/mol |
| Topological Polar Surface Area | 647 Ų |
| Heavy Atom Count | 134 |
| Formal Charge | 0 |
| Complexity | 3790 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 13 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 6 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Omiganan Pentahydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omiganan Pentahydrochloride, including repackagers and relabelers. The FDA regulates Omiganan Pentahydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omiganan Pentahydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Omiganan Pentahydrochloride supplier is an individual or a company that provides Omiganan Pentahydrochloride active pharmaceutical ingredient (API) or Omiganan Pentahydrochloride finished formulations upon request. The Omiganan Pentahydrochloride suppliers may include Omiganan Pentahydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Omiganan Pentahydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omiganan Pentahydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Omiganan Pentahydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Omiganan Pentahydrochloride DMFs exist exist since differing nations have different regulations, such as Omiganan Pentahydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omiganan Pentahydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Omiganan Pentahydrochloride USDMF includes data on Omiganan Pentahydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omiganan Pentahydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omiganan Pentahydrochloride suppliers with USDMF on PharmaCompass.
Omiganan Pentahydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omiganan Pentahydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omiganan Pentahydrochloride GMP manufacturer or Omiganan Pentahydrochloride GMP API supplier for your needs.
A Omiganan Pentahydrochloride CoA (Certificate of Analysis) is a formal document that attests to Omiganan Pentahydrochloride's compliance with Omiganan Pentahydrochloride specifications and serves as a tool for batch-level quality control.
Omiganan Pentahydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Omiganan Pentahydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omiganan Pentahydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Omiganan Pentahydrochloride EP), Omiganan Pentahydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omiganan Pentahydrochloride USP).
LOOKING FOR A SUPPLIER?
